科翔股份(300903) - 2023 Q3 - 季度财报

Financial Performance - The company's revenue for Q3 2023 reached ¥791,271,401.16, representing a year-on-year increase of 22.25%[5] - The net profit attributable to shareholders was a loss of ¥14,080,407.89, a significant decline of 186.95% compared to the same period last year[5] - The net profit attributable to shareholders after deducting non-recurring gains and losses was a loss of ¥40,443,912.69, down 549.09% year-on-year[5] - The basic earnings per share for Q3 2023 was -¥0.0340, a decrease of 185.43% year-on-year[5] - The net profit attributable to shareholders of the parent company decreased to -60,715,777.80 RMB, a decline of 193.00% compared to 65,286,661.39 RMB in the same period last year[12] - The total profit for Q3 2023 was a loss of CNY 97,259,200.00, down from a profit of CNY 55,483,353.28 in Q3 2022, indicating a substantial decrease[23] - Net profit attributable to shareholders of the parent company was a loss of CNY 60,715,777.80 in Q3 2023, compared to a profit of CNY 65,286,661.39 in Q3 2022, indicating a significant decline[24] - Other comprehensive income attributable to shareholders of the parent company was a loss of CNY 1,404,984.87 in Q3 2023[24] Assets and Liabilities - The total assets as of September 30, 2023, amounted to ¥6,914,881,316.04, reflecting an increase of 11.46% from the end of the previous year[5] - Total assets as of September 30, 2023, amounted to CNY 6,914,881,316.04, compared to CNY 6,207,175,948.03 at the beginning of the year, reflecting a growth of 11.4%[20] - Total liabilities increased to CNY 4,575,841,655.58 from CNY 3,824,470,189.23, marking an increase of 19.6%[20] - The company's total equity decreased to CNY 2,339,039,660.46 from CNY 2,382,705,758.80, a decline of 1.8%[20] - Total liabilities amounted to CNY 3,821,442,223.39, with current liabilities at CNY 3,396,357,296.62, and non-current liabilities at CNY 425,084,926.77[32] - The company’s total liabilities and equity amounted to CNY 6,207,175,948.03[33] Cash Flow - The company's cash flow from operating activities showed a net outflow of ¥94,883,692.69, a decrease of 1.39% compared to the previous period[5] - The net cash flow from operating activities was -94,883,692.69, compared to -93,579,698.08 in the previous year, indicating a slight decline in operational cash generation[26] - The net cash flow from investing activities improved by 43.45%, amounting to -715,224,870.08 RMB, compared to -1,264,725,168.28 RMB in the previous year[12] - The net cash flow from financing activities decreased by 64.84%, totaling 461,012,010.76 RMB, primarily due to the completion of a specific stock issuance in the previous year[12] - The total cash inflow from investment activities was 3,004,597,398.55, down from 3,310,948,121.37, reflecting a decrease in investment returns[26] - The net cash flow from financing activities increased to 461,012,010.76 from 1,311,113,721.00, showing a significant drop in financing cash inflow[26] - The total cash and cash equivalents at the end of the period stood at 421,183,532.75, compared to 249,919,081.41 at the end of the previous year, indicating an increase in liquidity[27] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 29,824, with no preferred shareholders[13] - The largest shareholder, Zheng Xiaorong, holds 14.83% of the shares, amounting to 61,505,431 shares, with 37,040,000 shares pledged[13] - The second-largest shareholder, Tan Dong, owns 11.60% of the shares, totaling 48,104,750 shares[13] Expenses and Impairments - The company reported a significant increase in asset impairment losses, totaling -25,662,394.88 RMB, reflecting a 394.41% rise due to declining orders and prices[12] - The company experienced a 95.94% decrease in other income, which amounted to 363,558.23 RMB, primarily due to a reduction in listing subsidies[12] - The company reported a 50.89% increase in credit impairment losses, totaling -15,743,078.01 RMB, attributed to changes in expected credit losses on accounts receivable[12] - Research and development expenses increased to CNY 133,697,310.78 in Q3 2023 from CNY 124,159,641.17 in Q3 2022, reflecting a growth of about 7.4%[23] - The company experienced a financial expense of CNY 4,825,629.57 in Q3 2023, compared to an income of CNY 16,397,270.56 in Q3 2022, indicating a significant change in financial performance[23] Other Financial Metrics - The company received government subsidies amounting to ¥26,924,396.55 during the reporting period, contributing to its financial performance[6] - The company reported an investment income of CNY 12,102,706.96 in Q3 2023, up from CNY 9,060,594.13 in Q3 2022, reflecting an increase of approximately 33.7%[23] - The total operating costs for Q3 2023 were CNY 2,292,562,855.37, up from CNY 1,889,996,825.63 in Q3 2022, representing an increase of approximately 21.4%[23] - The company has a total of 61,505,431 shares under lock-up, with a planned release date in November 2023[16]